Laurus Labs gets 2 USFDA observations for Visakhapatnam facility Ruchika Sharma11 Feb 2023 1:15 PM ISTTelangana: Laurus Labs has announced that the company has received Form 483 with two observations from the US Food and Drug Administration (USFDA)...
USFDA issues zero observations for Gland Pharma Visakhapatnam API facility Ruchika Sharma28 Jan 2023 1:00 PM ISTVisakhapatnam: Gland Pharma has recently announced that the company has received zero observations from the US Food and Drug Administration (USFDA)...
Laurus Labs gets 1 USFDA observation for Visakhapatnam facility Ruchika Sharma29 Oct 2022 3:32 PM ISTHyderabad: Laurus Labs today announced that the US Food and Drug Administration (USFDA) has concluded a PreApproval Inspection (PAI) with...
